Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 54Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Neoplasm Metastasis 4Sarcoma, Ewing 3Neoplasms 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioblastoma 2Ependymoma 2Colonic Neoplasms 2Xanthogranuloma, Juvenile 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Teratoma 1Recurrent Squamous Cell Lung Carcinoma 1

Interventions

Doxorubicin 6pazopanib 5Trabectedin 4Radiotherapy 3temsirolimus 2eribulin 2Sunitinib 2Radiotherapy, Conformal 2Ifosfamide 2Dexamethasone 2sitravatinib 1selinexor 1saracatinib 1romidepsin 1regorafenib 1plitidepsin 1pembrolizumab 1palbociclib 1olaratumab 1milademetan 1liposomal doxorubicin 1lenvatinib 1indolepropanol phosphate 1efatutazone 1cixutumumab 1brigimadlin 1avelumab 1atezolizumab 1Watchful Waiting 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Liposarcoma × palbociclib × Clear all
NCT01209598 2017-11-06

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
90 enrolled 7 charts
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡